Learning Lounge:
Appropriate use of ORBACTIV® (oritavancin) for injection, a novel single dose regimen for treating ABSSSI (Not Official IDWeek Programming - Supported by The Medicines Company - See Affiliated Event Guide)
Thursday, October 8, 2015: 12:15 PM-1:00 PM
Room: IDExpo Hall, Learning Lounge 1 (Booth 115)

Learning Objectives:


Dino J Delaportas, MD, FACP

Infectious Disease Specialist

Mon General Hospital

Morgantown, West Virginia


Jonathan Edwards, Pharm.D., BCPS-AQ ID, CGP

Infectious Disease Pharmacist

Huntsville Hospital Health Systems

Huntsville, Alabama


Note: Lunch will be provided.

Target Audience: Infectious diseases physicians

CME Credits:

ACPE Credits:

ACPE Number:

See more of: Learning Lounge

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 7th with the exception of research findings presented at the IDWeek press conferences.